DOTA-lanreotide: A novel somatostatin analog for tumor diagnosis and therapy

Endocrinology

Volumn 140, Issue 11, 1999, Pages 5136-5148

  Smith Jones, Peter M ^a   Bischof, Claudia ^a   Leimer, Maria ^a   Gludovacz, Doris ^a   Angelberger, Peter ^b   Pangerl, Thomas ^a   Peck Radosavljevic, Markus ^a   Hamilton, Gerhard ^a   Kaserer, Klaus ^a   Kofler, Anne ^a   Schlagbauer Wadl, Hermine ^a   Traub, Tatjana ^a   Virgolini, Irene ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b ARC SEIBERSDORF RESEARCH GMBH   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID; 1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID ANGIOPEPTIN; 1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID ANGIOPEPTIN INDIUM IN 111; 1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID ANGIOPEPTIN YTTRIUM Y 90; ANGIOPEPTIN; INDIUM 111; OCTREOTIDE; SOMATOSTATIN DERIVATIVE; UNCLASSIFIED DRUG; VAPREOTIDE; YTTRIUM 90;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; BREAST CANCER; CANCER; CANCER CELL CULTURE; CANCER DIAGNOSIS; CANCER THERAPY; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; HUMAN; HUMAN CELL; HUMAN TISSUE; INTESTINE CARCINOMA; ISOTOPE LABELING; NONHUMAN; PRIORITY JOURNAL;

EID: 0033303656     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.140.11.7126     Document Type: Article

References (48)

1. Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone
2. Dissociation of antiproliferative and antihormonal effects of the somatostatin analog octreotide on 7315b pituitary tumor cells
3. Activation of human somatostatin receptor type 2 causes inhibition of cell growth in transfected HEK293 but not in transfected CHO cells
4. Somatostatin and growth hormone regulation in cancer
5. Cloning and functional characterization of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract, and kidney
6. Somatostatin receptors, an expanding gene family: Cloning and functional characterization of human SSTR3, a protein coupled to adenylyl cyclase
7. A human somatostatin receptor (SSTR3), located on chromosome 22, displays preferential affinity for somatostatin-14 like peptides
8. Cloning and expression of a human somatostatin-14-selective receptor variant (somatostatin receptor 4) located on chromosome 20
9. Cloning and characterization of a fourth human somatostatin receptor
10. Cloning, functional expression and pharmacological characterization of a fourth (hsst4) and a fifth (hsst5) human somatostatin receptor subtype
11. Molecular cloning, functional characterization, and chromosomal localization of a human somatostatin receptor (somatostatin receptor type 5) with preferential affinity for somatostatin-28
12. Somatostatln receptor subtype specificity in human fetal pituitary cultures. Differential role of SSTR2 and SSTR5 for growth hormone, thyroid-stimulating hormone and prolactin regulation
13. Induction of a negative autocrine loop by expression of SST2 somatostatin receptor in NIH 3T3 cells
14. SST2:Somatostatin receptor expression reverses tumorigenicity of human pancreatic cancer cells
15. Subtype-selective induction of wild-type p53 and apoptosis, but not cell cycle arrest, by human somatostatin receptor 3
16. Cross-competition between vascoactive intestinal peptide and somatostatin for binding to tumor cell membrane receptors
17. The role of somatostatin and its analogs in the diagnosis and treatment of tumors
18. Somatostatin receptor subtype expression in human tissues: A prediction for diagnosis and treatment of Cancer
19. Sandostatin in the management of nonendocrine gastrointestinal and pancreatic disorders: A preliminary study
20. Clinical results of long term slow release lanreotide treatment of acromegaly
21. Vapreotide, a new somatostatin analogue in the palliative management of obstructive ileus in advanced cancer
22. Drug therapy: Octreotide
23. 3]-octreotide: The Rotterdam experience with more than 1000 patients
24. Gallium-67/gallium-68-[DFO]-octreotide: A potential radiopharmaceutical for PET imaging of somatostatin receptor-positive tumors: Synthesis and radiolabeling, in vitro and preliminary in vivo studies
25. In vitro and in vivo evaluation of copper-64 octreotide conjugates
26. 111In-DTPA-D-Phe-1-OCT
27. 99mTc-P829
28. Somatostatin receptor scintigraphy and radionuclide therapy
29. Radiation spectra for auger electron emitting radionuclides: Report no. 2 of AAPM nuclear medicine task group no. 6
30. 111In-octreotide - Preliminary results
31. Indium-111-DOTA-Lanreotide: Biodistribution, safety and tumor dose in patients evaluated for somatostatin receptor-mediated radiotherapy
32. 'MAURITIUS:' Biodistribution and tumor dose in patients evaluated for somatostatin receptor (SSTR)-mediated radiotherapy
33. Response to treatment with yttrium-90-DOTA-lanreotide of a patient with metastatic gastrinoma
34. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
35. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
36. The attraction of proteins for small molecules and ions
37. 3-octreotide a promising somatostatin analogue for radionuclide therapy
38. 90Y-SMT 487) eradicated experimental rat pancreatic CA 20948 tumours
39. Somatostatin analogues for somatostatin-receptor-mediated radiotherapy of cancer
40. Synthesis, radiochemistry and biological evaluation of a new somatostatin analogue (SDZ 219-387) labelled with technetium-99m
41. Estrogen regulates somatostatin receptor subtype 2 messenger ribonucleic acid expression in human breast cancer cells
42. Direct inhibitory effects of somatostatin (analogues) on the growth of human breast cancer cells
43. Internalization of isotope-coupled somatostatin analogues
44. Indium-111-diethylenetriaminepentaacetic acid-octreotide is delivered in vivo to pancreatic, tumor cell, renal, and hepatocyte lysosomes
45. Comparison of four bifunctional chelates for radiolabeling monoclonal antibodies with copper radioisotopes: Biodistribution and metabolism
46. -tetraacetic acid
47. Design and synthesis of macrocyclic ligands and their complexes with lanthanides and actinides